Results 1 to 10 of about 7,774 (176)

A Rare Complication of Trimethoprim-Sulfamethoxazole: Drug Induced Aseptic Meningitis [PDF]

open access: yesCase Reports in Infectious Diseases, 2016
Drug induced aseptic meningitis is a rare but challenging diagnosis, most commonly reported with nonsteroidal anti-inflammatory drugs and antibiotics.
Pinky Jha   +3 more
doaj   +12 more sources

Drug-Induced Aseptic Meningitis Following Spinal Anesthesia [PDF]

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2019
Meningitis is a very uncommon complication of spinal anesthesia, and drug-induced aseptic meningitis (DIAM) is even rarer. We present two cases of DIAM following spinal anesthesia with bupivacaine and ropivacaine, respectively.
Ricardo Paquete Oliveira   +5 more
doaj   +6 more sources

Drug-Induced Aseptic Meningitis Associated With Intrathecal Trastuzumab. [PDF]

open access: yesJ Pharm Technol, 2014
Objective: To report a case of drug-induced aseptic meningitis (DIAM) in a patient receiving intrathecal trastuzumab (ITT) for leptomeningeal carcinomatosis (LC) secondary to HER-2/neu positive breast cancer. Case Summary: A 43-year-old female with stage IV breast cancer presented with headache, parasthesias, and aphasia.
Freyer CW   +3 more
europepmc   +4 more sources

The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network. [PDF]

open access: yesPLoS ONE, 2013
Ipilimumab, a cytotoxic T-lymphocyte antigen-4 (CTLA-4) blocking antibody, has been approved for the treatment of metastatic melanoma and induces adverse events (AE) in up to 64% of patients.
Caroline J Voskens   +35 more
doaj   +7 more sources

Drug-induced aseptic meningitis: 329 cases from the French pharmacovigilance database analysis. [PDF]

open access: yesBr J Clin Pharmacol, 2019
AimsDrug‐induced aseptic meningitis (DIAM) is an adverse drug reaction of exclusion; only few studies have addressed this iatrogenic disease. The aim was to characterize DIAM and to identify suspected drugs.MethodsData were collected from the analysis of the French Pharmacovigilance Database from inception (1 January 1985) to 8 March 2017.
Bihan K   +4 more
europepmc   +4 more sources

A Case of Trimethoprim‐Sulfamethoxazole Associated Aseptic Meningitis [PDF]

open access: yesClinical Case Reports
Most cases of aseptic meningitis, or nonsuppurative meningitis, are caused by viruses or systemic diseases. Nonetheless, drug‐induced aseptic meningitis should be considered in the differential diagnosis, particularly with the recent use of antibiotics ...
Malik W. Z. Khan   +6 more
doaj   +2 more sources

Pathogenesis and predisposing factors in drug-induced aseptic meningitis: A case study

open access: yesNew Zealand Medical Student Journal, 2022
Aseptic meningitis is the inflammation of the meningeal membranes in the absence of an identifiable pathogen. While viruses are the most common culprit, bacteria, fungi, rheumatological conditions, and neoplastic processes are also known causes.
Avroneel Ghosh
doaj   +2 more sources

Drug induced aseptic meningitis: A diagnostic challenge [PDF]

open access: yesNigerian Journal of Paediatrics, 2014
Drug-induced aseptic meningitis (DIAM) is a rare but important and often challenging diagnosis for the physician. Intake of antimicrobials, steroids, analgesics amongst others has been implicated.
Frank-Briggs, AI, Oluwatade, OJ
core   +5 more sources

A Dilemma in the Diagnosis of Group A Streptococcus (GAS) Meningitis Versus Drug-Induced Aseptic Meningitis: A Case Report. [PDF]

open access: yesCureus
Group A Streptococcus (GAS), also called Streptococcus pyogenes, is a rare cause of adult meningitis. In recent years, many outbreaks of invasive S. pyogenes infections in Europe, involving the emm1.0 subtype of the M1UK lineage, have led to a rising prevalence of GAS meningitis.
Sharma R   +4 more
europepmc   +3 more sources

A Case of Drug-Induced Aseptic Meningitis Caused by Rozanolixizumab in a Patient With Myasthenia Gravis

open access: yesAnnals of Internal Medicine: Clinical Cases
Rozanolixizumab, a novel therapeutic medication for myasthenia gravis (MG), is a humanized monoclonal antibody against the neonatal Fc receptor. Sold under the brand name Rystiggo, it is the first treatment that the U.S.
Herisha Shah   +2 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy